Hangzhou Tianmushan Pharmaceutical Enterprise Co LtdSSE: 600671

2025 Semi-annual Report

Aug 28, 2025 · Issued by Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd via Shanghai Stock Exchange

Filed with SSE · Aug 28, 2025

On 6ix: 6ix.com/news/2025-semi-annual-report-221

2025 Semi-annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd on 6ix

Earlier from Hangzhou Tianmushan Pharmaceutical Enterprise

Announcement on Obtaining Notice of Approval for Re-Registration of Drug by the SubsidiaryJul 24, 2025
Announcement on Expected Increase in Semi-annual Performance for 2025Jul 15, 2025
Announcement on Outline of the 2024 Annual Performance BriefingJun 6, 2025
Announcement on Convening the 2024 Annual Performance BriefingMay 27, 2025
Announcement on Reply to Letter from Shanghai Stock Exchange on Information SupervisionMay 17, 2025

Later from Hangzhou Tianmushan Pharmaceutical Enterprise

Announcement on Resolutions of the 15th Meeting of the 12th Board of DirectorsSep 3, 2025
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025Sep 13, 2025
Announcement on Convening the 2025 Semi-annual Performance BriefingSep 17, 2025
Announcement on Outline of the 2025 Semi-annual Performance BriefingSep 26, 2025
Announcement on Reply to Letter from Shanghai Stock Exchange on Information Disclosure and SupervisionSep 27, 2025

All Hangzhou Tianmushan Pharmaceutical Enterprise news releases

Follow Hangzhou Tianmushan Pharmaceutical Enterprise into a list and get an email when it puts out news.

Follow Hangzhou Tianmushan Pharmaceutical Enterprise